Literature DB >> 5931742

A classification of LSD complications.

S Cohen.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5931742     DOI: 10.1016/S0033-3182(66)72149-5

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  9 in total

Review 1.  Non-medical use of drugs with particular reference to youth.

Authors: 
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

2.  Persisting psychotic states in adolescent drug users.

Authors:  J W Duncan
Journal:  Child Psychiatry Hum Dev       Date:  1974

3.  Drug-taking by the young.

Authors: 
Journal:  Br Med J       Date:  1967-04-08

4.  Adverse reactions from the illicit use of lysergide.

Authors:  T H Bewley
Journal:  Br Med J       Date:  1967-07-01

Review 5.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

Review 6.  d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.

Authors:  Danilo De Gregorio; Stefano Comai; Luca Posa; Gabriella Gobbi
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

Review 7.  Serotonin and brain function: a tale of two receptors.

Authors:  R L Carhart-Harris; D J Nutt
Journal:  J Psychopharmacol       Date:  2017-08-31       Impact factor: 4.153

8.  The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.

Authors:  Max Wolff; Lea J Mertens; Marie Walter; Sören Enge; Ricarda Evens
Journal:  J Psychopharmacol       Date:  2022-03       Impact factor: 4.153

Review 9.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.